Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial Documento uri icon

  •  
  • Visão geral
  •  
  • Identidade
  •  
  • Informação adicional documento
  •  
  • Outro
  •  
  • Ver todos
  •  

tipo

  • journal article

data de publicação

  • 2021-01-01